Related Experiment Video

Updated: Aug 13, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or

S Israilov1, E Niv, P M Livne

  • 1Institute of Urology, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49110, Israel.

International Journal of Impotence Research
|March 16, 2002
PubMed

Insights

A progressive intracavernous injection program effectively treated erectile dysfunction in cardiovascular disease patients unresponsive to oral medications. This treatment achieved a 94.3% success rate, offering a viable alternative for managing sexual health in this population.

Area of Science:

  • Cardiovascular Medicine
  • Urology
  • Pharmacology

Background:

  • Erectile dysfunction (ED) is common in patients with cardiovascular disease (CVD).
  • Sildenafil citrate (Viagra) is often contraindicated in CVD patients.
  • Alternative ED treatments are crucial for this population.

Purpose of the Study:

  • To assess the efficacy of a progressive intracavernous injection (ICI) program for ED treatment.
  • To evaluate ICI as an alternative for CVD patients unsuitable for oral ED medication.

Main Methods:

  • A cohort of 106 CVD patients with ED participated.
  • A three-protocol ICI regimen using vasoactive drugs (papaverine, phentolamine, prostaglandin E1, atropine sulfate) was administered progressively.
  • Treatment success was defined as achieving an erection sufficient for vaginal penetration.

Main Results:

  • Overall success rate was 94.3% across the three protocols.
  • Protocol I: 57.5% success; Protocol II: 71.1% success; Protocol III: 53.8% success.
  • At 1-year follow-up, 90% of patients reported successful intercourse, with 87.8% using ICI.

Conclusions:

  • Progressive ICI therapy is a highly effective treatment for ED in patients with CVD.
  • ICI provides a safe and successful alternative for managing ED when oral agents are not an option.
  • The program demonstrated sustained efficacy and patient satisfaction over a 1-year period.

More Related Videos

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...